COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement

NCT03675971 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Arthroplasty, Replacement, Knee

Interventions

DRUG: Cannabinol
DRUG: Placebo oral capsule

Sponsor

Unity Health Toronto